Gentis
Wayne
About Gentis
Gentis is a developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spine. The company's patented product is DiscCell, an injectable, in-situ setting, radio-opaque, non-hydrogel polymer material that augments or replaces the diseased nucleus pulposus of the spinal disc. Gentis was founded on 2000 and is headquartered in Wayne, Pennsylvania.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.5M
- Last round: Series Unknown (Jul 2010)
- Website: gentisinc.com
- Phone: 610-971-0990
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/gentis-2166582 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.